Navigation Links
Questcor Reports Third Quarter Financial Results
Date:10/29/2013

)—Other accrued liabilities3,424946Other non-current liabilities4(259)Net cash flows provided by operating activities231,847135,349INVESTING ACTIVITIESPurchase of property and equipment(1,647)(651)Purchase of short-term investments(61,678)(122,776)Proceeds from maturities of short-term investments120,807167,524Restricted cash associated with the acquisition of Synacthen(75,000)—Acquisition of BioVectra, net of cash acquired(46,692)—Acquisition of Synacthen(60,000)—Proceeds from sale of Doral700—Deposits and other assets727(14)Net cash flows (used in) / provided by investing activities(122,783)44,083FINANCING ACTIVITIESRepayment of funded long-term debt(925)—Repayment of other long-term debt(374)—Income tax benefit realized from share-based compensation plans15,4126,678Dividends paid(29,895)—Issuance of common stock, net16,0784,698Repurchase of common stock—(243,201)Net cash flows provided by / (used in) financing activities296(231,825)Effect of cash on changes in exchange rates877—Increase (decrease) in cash and cash equivalents110,237(52,393)Cash and cash equivalents at beginning of period80,60888,469Cash and cash equivalents at end of period$

190,845$

36,076Supplemental Disclosures of Cash Flow Information:Cash paid for interest$

554$

17Cash paid for income taxes$

89,765$

54,024Supplemental Disclosures of Investing and Financing Activities:Dividend payable$

—$

11,691In conjunction with the acquisition of BioVectra at January 18, 2013:Incremental fair value of assets acquired, net$

80,698Less: fair value of contingent consideration(30,383)50,315Loss on foreign exchange rate488Total cash paid for acquisition of BioVectra$

50,803
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
2. Questcor to Report Second Quarter Results on July 24, 2012
3. Questcor Reports Second Quarter Financial Results
4. Questcor Pharmaceuticals to Present at Investor Conferences in September
5. Questcor and The Myositis Association Team Up To Support Research and Educational Initiatives in Polymyositis and Dermatomyositis
6. Questcor Comments on Insurance Policy Bulletin
7. Questcor to Conduct Conference Call to Discuss Reimbursement Process
8. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
9. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
10. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
11. Questcor to Report Fourth Quarter and Full Year 2012 Financial Results on February 26, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/w3n5p6/drug_delivery_in ) has ... "Drug Delivery in Central Nervous System Diseases ... offering. The delivery of drugs to ... the treatment of neurological disorders. Drugs may be ... (e.g., by intravenous injection) for targeted action in ...
(Date:6/2/2015)... Canadian Society for Vascular Surgery (CSVS) today released ... that are commonly ordered but not always necessary ... Canada.  The list identifies five (5) targeted, evidence-based ... physicians about what care is really necessary. ... identified the following five (5) recommendations: ...
(Date:6/2/2015)... , June 02, 2015 Research and Markets ( ... Archiving and Communication Systems (PACS) - Global Strategic Business Report" ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin America ... and forecasts are provided for the period 2014 through 2020. ...
Breaking Medicine Technology:Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 2Global Drug Delivery in Central Nervous System Diseases Report 2015-2024 - Technologies, Markets and Companies 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4Picture Archiving and Communication Systems (PACS) - Global Strategic Business Report 2015: User Demand Favors Integrated RIS/PACS Solutions 2
(Date:6/2/2015)... June 02, 2015 UCLA Health and ... intent to partner and expand urgent care services in ... approval by the University of California Board of Regents ... will allow UCLA Health to purchase a minority share ... Hills, Calabasas, Newbury Park and Northridge and creates opportunity ...
(Date:6/2/2015)... TMG Health, the leading national provider ... the Medicare Advantage, Medicare Part D, and Managed Medicaid ... at AHIP’s Institute 2015, the annual meeting of the ... will be held June 3-5 in Nashville, Tenn. , ... for attendees to schedule private discussions with senior members ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 On October ... congressional efforts for another delay. , On Monday, ... Health Subcommittee for the House Ways and Means Committee, ... to Centers for Medicare and Medicaid Services, urging the ... as CMS rolls out ICD-10. ICD-10 is the newest ...
(Date:6/2/2015)... Angeles, California (PRWEB) June 02, 2015 ... sealers and sorbent systems, has announced the availability ... accidental ingestion of poisons by children, especially curious ... ASTM D3475 standards and tested to CFR 1700.20 ... Director Kevin Cullen. , Looks Like Candy, “With ...
(Date:6/2/2015)... June 02, 2015 Olive ... opening of Surrey’s first fertility clinic. Surrey ... a diverse, young community, with one of ... , Until now patients from Surrey ... to come into Vancouver or Burnaby for ...
Breaking Medicine News(10 mins):Health News:UCLA Health Partners With Exer - More Than Urgent Care 2Health News:TMG Health to Sponsor and Exhibit at AHIP’s Institute 2015 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 2Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 3Health News:HomeTown Health Launches a “100 Day Countdown” in Response to ICD-10 Survey 4Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2Health News:Olive Fertility Centre Opens First Fertility Clinic in Surrey BC 2
... women's with damaged or missing wombs by saying in ... to have children normally. // ,After ... transplantation would be possible in humans too without any ... syndrome (a rare congenital condition affecting womb) can also ...
... health boards' (DHB) long running disagreement over the funding of ... are forced to travel to Christchurch for specialist treatment. ... the treatment of cervical and other gynecological cancers and was ... has still not been ordered because the DHB wants other ...
... plague is a respiratory disease and is endemic to the ... to occur//. If the disease is not diagnosed at an ... If diagnosed at an early stage then the patient can ... disease has already killed 22 people and this highly contagious ...
... Institute for Public Health had reported on Thursday that a ... of mad cow disease, last year a woman died from ... Environment (RIVM) did not however disclose any further details about ... issue a statement that eating contaminated meat products would have ...
... in Germany have announced progress in their collaborative ... the treatment of hemophilia. ,Extensive in ... synthetic lead molecules with promising pharmacological properties. ... to make important progress in our collaboration with ...
... against sunscreen manufacturers in California as they had exaggerated the ... hand still recommend the liberal use of sunscreen. But some ... the label on the products gives a clear picture to ... but do cause aging of the skin and potentially cancer. ...
Cached Medicine News:Health News:Advance in Program for Development of Non-Intravenous Therapy for Hemophilia 2Health News:Advance in Program for Development of Non-Intravenous Therapy for Hemophilia 3
Femoral selective diagnostic catheter.The material used is polyurethane (DUCOR). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Coronary angiographic catheter...
The entirely open modular system is especially suitable for stereotactic microsurgical procedures....
Used to negotiate tortuous vessels....
Medicine Products: